08:56 28/06/2025
icon facebook icon twitter icon pinterest
Nguồn tham khảo
  1. New York Heart Association (NYHA) classification. (n.d.-b). https://manual.jointcommission.org/releases/TJC2018A/DataElem0439.html
  2. Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldmanmd, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., Noble, R. J., Packer, M., Silver, M. A., Stevenson, L. W., Gibbons, R. J., Antman, E. M., Alpert, J. S., Faxon, D. P., Fuster, V., . . . Smith, S. C. (2001). ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation, 104(24), 2996–3007. https://doi.org/10.1161/hc4901.102568
  3. Chow, J., & Senderovich, H. (2018). It’s time to talk: Challenges in providing Integrated palliative care in advanced congestive heart Failure. A narrative review. Current Cardiology Reviews, 14(2), 128–137. https://doi.org/10.2174/1573403×14666180123165203
  4. Jones, N. R., Roalfe, A. K., Adoki, I., Hobbs, F. R., & Taylor, C. J. (2019). Survival of patients with chronic heart failure in the community: a systematic review and meta‐analysis. European Journal of Heart Failure, 21(11), 1306–1325. https://doi.org/10.1002/ejhf.1594
Chủ đề:
Banner ECO Pharma 15 năm

ĐẶT CÂU HỎI